Neurological manifestations of schistosomiasis are rare. Early treatment can prevent disability.
Correspondence to Dr Olga Mikulich, drmikulich@gmail.com An MRI of the spine showed increased signal/ mass-effect in the spinal cord from the T6 level down to conus medullaris and mild patchy enhancement of the abnormality following intravenous contrast (figures 1 and 2).
Differential diagnosis included: astrocytoma, ependymoma, haemangioblastoma, schistosoma mass and metastases. In the patient from a highly endemic area, presenting with subacute myeloradiculopathy and MRI findings suggesting spinal cord schistosomiasis, cerebrospinal fluid (CSF) studies were performed prior to pursuing tissue diagnosis.
CSF schistosomal antibodies were strongly positive, protein elevated (117 mg/dL).
Extraspinal manifestations of schistosomiasis were absent.
Treatment was initiated by dexamethasone 4 mg four times a day with dramatic clinical improvement. Following CSF results praziquantel 25 mg/kg, three doses and prednisolone 1 mg/kg were given.
Four days after praziquantel initiation patient re-presented with increasing leg weakness and urinary retention. This resolved quickly with intravenous steroids and was felt to be a response to inflammatory mediators release following praziquantel.
MRI during 19 days showed marked interval decrease in the abnormal signal and swelling in the spinal cord.
Corticosteroids and antischistosoma drugs should be administered as early as possible. Steroid therapy may be prolonged, relapse following praziquantel anticipated. MRI often shows abnormalities in lower thoracic cord/conus due to anastomosis between the pelvic veins and valveless vertebral venous plexi. 2 Presence of the MRI abnormalities strengthens presumptive diagnosis in appropriate clinical setting to expedite treatment and avoid invasive procedures.
Learning points
▸ Spinal cord schistosomiasis may present as a spinal cord syndrome. ▸ High index of suspicion in MRI interpretation helps to avoid invasive investigations and to expedite treatment for disability-free survival. ▸ Relapse following praziquantel initiation could be anticipated.
